Skip to main content
Acta Crystallographica Section A: Foundations and Advances logoLink to Acta Crystallographica Section A: Foundations and Advances
. 2018 Oct 30;74(Pt 6):709. doi: 10.1107/S2053273318014079

Ab initio structure determination of nanocrystals of organic pharmaceutical compounds by electron diffraction at room temperature using a Timepix quantum area direct electron detector. Corrigendum

E van Genderen a,b, M T B Clabbers a,b, P P Das c, A Stewart d, I Nederlof a,e, K C Barentsen a, Q Portillo c,f, N S Pannu a, S Nicolopoulos c, T Gruene g,*, J P Abrahams a,b,g,*
PMCID: PMC6207913  PMID: 30378582

A correction is made to the article by van Genderen et al. [Acta Cryst. (2016), A72, 236–242].

Keywords: electron nanocrystallography, Timepix quantum area detector, carbamazepine, nicotinic acid, electron diffraction structure determination

Abstract

Corrections are made to Table 1 in the article by van Genderen et al. [Acta Cryst. (2016), A72, 236–242].


In the article by van Genderen et al. (2016), the scattering factors used in the refinements and in the CIF file were for X-ray scattering rather than for electron scattering. The correct scattering factors have now been used and the statistics that were affected by this error (model statistics R complete, R1 and wR2) have been recalculated.

This affects six entries in Table 1 of the original publication. The correct values are given here. The corrected CIF and supporting information are also made available.

Table 1. Corrected statistics.

  Carbamazepine Nicotinic acid
Refinement statistics
R complete 31.8 37.7
R1 (%) 27.9 34.1
wR2 (%) 55.2 60.1

Luebben & Gruene (2015).

Supplementary Material

Crystal structure: contains datablock(s) global, carbamazepine_single, carbamazepine_5x-merged, nicotinic_acid_single, nicotinic_acid_2x-merged. DOI: 10.1107/S2053273318014079/td9026sup1.cif

a-74-00709-sup1.cif (400.6KB, cif)

Supporting information file. DOI: 10.1107/S2053273318014079/td9026sup2.pdf

a-74-00709-sup2.pdf (90.1KB, pdf)

CCDC references: 1438802, 1438803, 1438804, 1438805, 1438806

Acknowledgments

The authors are grateful to Professor Ton Spek, Utrecht University, The Netherlands, for alerting them to this error.

References

  1. Genderen, E. van, Clabbers, M. T. B., Das, P. P., Stewart, A., Nederlof, I., Barentsen, K. C., Portillo, Q., Pannu, N. S., Nicolopoulos, S., Gruene, T. & Abrahams, J. P. (2016). Acta Cryst. A72, 236–242. [DOI] [PMC free article] [PubMed]
  2. Luebben, J. & Gruene, T. (2015). Proc. Natl Acad. Sci. USA, 112, 8999–9003. [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) global, carbamazepine_single, carbamazepine_5x-merged, nicotinic_acid_single, nicotinic_acid_2x-merged. DOI: 10.1107/S2053273318014079/td9026sup1.cif

a-74-00709-sup1.cif (400.6KB, cif)

Supporting information file. DOI: 10.1107/S2053273318014079/td9026sup2.pdf

a-74-00709-sup2.pdf (90.1KB, pdf)

CCDC references: 1438802, 1438803, 1438804, 1438805, 1438806


Articles from Acta Crystallographica. Section A, Foundations and Advances are provided here courtesy of International Union of Crystallography

RESOURCES